News CVS Health Corporation

Equities

CVS

US1266501006

Market Closed - Nyse Other stock markets 04:00:02 2024-05-03 pm EDT			5-day change	1st Jan Change
55.9 ^USD	+1.36%		-16.79%	-29.20%

May. 03	Aetna will cover fertility treatments for LGBTQ people under court settlement	RE
May. 03	ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aetna agrees to settle lawsuit over fertility coverage for LGBTQ+ customers	May. 03	AQ
Aetna will cover fertility treatments for LGBTQ people under court settlement	May. 03	RE
ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80	May. 03	MT
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors	May. 03	BU
Wall Street rises thanks to good and bad economic news	May. 03
North American Morning Briefing : Apple, Amgen -2-	May. 03	DJ
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91	May. 03	MT
Law Offices of Howard G. Smith Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors	May. 02	BU
The Law Offices of Frank R. Cruz Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors	May. 02	BU
Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing	May. 02	MT
Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77	May. 02	MT
Raymond James Adjusts Price Target on CVS Health to $65 From $85	May. 02	MT
Wolfe Adjusts Price Target on CVS Health to $70 From $88	May. 02	MT
Morgan Stanley Adjusts Price Target on CVS Health to $65 From $85	May. 02	MT
Jefferies Adjusts Price Target on CVS Health to $72 From $95	May. 02	MT
Barclays Adjusts Price Target on CVS Health to $63 From $78	May. 02	MT
Bernstein Adjusts Price Target on CVS Health to $62 From $93	May. 02	MT
Mizuho Adjusts Price Target on CVS Health to $72 From $86	May. 02	MT
Truist Lowers CVS Health's PT to $66 From $90 After Below-Consensus Q1 Results, Reduced Guidance; Keeps Buy Rating	May. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CVS Health Corporation

Equities

CVS

US1266501006

Summary

Filters